Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

APOMOPP:LX

130.83 EUR 0.22 0.17%

As of 00:59:30 ET on 04/24/2015.

Snapshot for APO Medical Opportunities (APOMOPP)

Year To Date: +13.11% 3-Month: +9.99% 3-Year: +24.56% 52-Week Range: 101.30 - 131.25
1-Month: +1.66% 1-Year: +27.80% 5-Year: +16.79% Beta vs LUXXX: 0.58

Mutual Fund Chart for APOMOPP

No chart data available.
  • APOMOPP:LX 130.83
  • 1M
  • 1Y
Interactive APOMOPP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for APOMOPP

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: 08-31-2005 Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for APOMOPP

NAV (on 2015-04-24) 130.83
Assets (M) (on 2015-04-24) 195.14
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for APOMOPP

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for APOMOPP

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.57
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.96

Top Fund Holdings for APOMOPP

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 67,406 6,210,185 3.220%
Bayer AG 34,459 4,802,286 2.490%
Pfizer Inc 142,138 4,609,423 2.390%
Amgen Inc 29,511 4,397,274 2.280%
Abbott Laboratories 94,230 4,069,407 2.110%
GlaxoSmithKline PLC 185,739 3,972,976 2.060%
BioMarin Pharmaceutical Inc 32,209 3,741,540 1.940%
Shanghai Pharmaceuticals Holdi 1,386,068 3,432,960 1.780%
Sanofi 36,924 3,394,387 1.760%
H Lundbeck A/S 157,361 3,085,806 1.600%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil